Highest-conviction names merged from Sector Rotation, current Stage 2/VCP, and the Portfolio Strategy Lab best strategy, with technical · available fundamental · risk-reward · extension analysis.
| # | Symbol | Sector | Sub-sector | Price | Stage | Inv.Score | RS% | 6M Tgt | RR (4M) | Risk | Extension | Conviction | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SAILIFE | Metals & Mining | Unmapped | ₹1435.90 | STAGE_2 | 81.40 | 95.4% | ₹1,953 | 1.67× | 1.5 | NORMAL | MEDIUM | VCP+Sector |
| 2 | UNOMINDA | EV & Auto Ancillaries | Auto Ancillaries | ₹1251.30 | STAGE_2 | 76.60 | 59.6% | ₹1,501 | 1.45× | 1.5 | NORMAL | MEDIUM | VCP+Sector |
| 3 | KEI | Capital Goods & Industrials | Industrial Products | ₹5494.00 | STAGE_2 | 78.70 | 80.4% | ₹7,141 | 2.00× | 1.5 | NORMAL | HIGH | Sector+S2 |
| 4 | RRKABEL | Defence & Aerospace | Defence & Aerospace Manufacturing | ₹2869.90 | STAGE_2 | 77.60 | 99.2% | ₹3,839 | 1.10× | 3.0 | EXTENDED | HIGH | Sector+S2 |
| 5 | WELCORP | Metals & Mining | Unmapped | ₹2409.20 | STAGE_2 | 75.90 | 99.7% | ₹3,216 | 0.52× | 7.0 | OVEREXTENDED | MEDIUM | Sector+S2 |
| 6 | ABB | Capital Goods & Industrials | Industrial Products | ₹7504.00 | STAGE_2 | 75.20 | 87.0% | ₹9,486 | 1.89× | 1.5 | NORMAL | MEDIUM | Sector+S2 |
| 7 | PRICOLLTD | EV & Auto Ancillaries | Auto Ancillaries | ₹790.90 | STAGE_2 | 82.90 | 94.7% | ₹1,056 | 1.04× | 3.5 | EXTENDED | MEDIUM | Sector+S2 |
| 8 | ENDURANCE | EV & Auto Ancillaries | Auto Ancillaries | ₹2988.20 | STAGE_2 | 76.50 | 71.6% | ₹3,660 | 1.48× | 3.5 | EXTENDED | MEDIUM | Sector+S2 |
| 9 | ANTHEM | Other | Unmapped | ₹883.35 | STAGE_2 | 84.20 | 78.7% | ₹1,082 | 1.29× | 2.5 | EXTENDED | LOW | VCP |
| 10 | AETHER | Other | Unmapped | ₹1667.80 | STAGE_2 | 83.80 | 98.9% | ₹2,077 | 1.05× | 6.0 | OVEREXTENDED | MEDIUM | VCP |
Top picks are not selected from a single indicator. The report looks for names where market structure, sector strength, price action, strategy evidence, and risk/reward all point in the same direction.
scores.stage2_vcp_picks.The final rank balances Stage 2 trend quality, relative strength, sector leadership, VCP or breakout evidence, the swing research overlay, portfolio strategy confirmation, target/stop risk-reward, and fundamental quality. Triple-confirmed names where sector rotation + Stage 2/VCP + strategy evidence agree are prioritised, followed by dual-confirmed candidates with strong trend and acceptable risk.
A high-ranked pick is a research shortlist candidate, not a direct investment instruction. The strongest candidates combine Stage 2 structure, leadership versus the market, constructive sector context, defined stop-loss, and acceptable reward-to-risk.
Each card: candlestick chart with EMAs, S/R, pivots & entry/stop/targets · KPI tiles · LLM-narrated thesis · technicals · fundamentals · quarterly / annual / BS / CF · events · risk gauge.
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries [1]
Source: Company website · screener.in · live
Sai Life Sciences Ltd (SAILIFE) presents a compelling bullish case with a recent price of ₹1435.9, boosted by an impressive revenue CAGR of 16.6% over the past four years, alongside a PAT CAGR of 145.3%. The technicals are solid with the stock exhibiting a bullish stance and maintaining a strong relative strength (RS) of 95.4% against Nifty 500. The latest quarter displayed revenue growth of ₹554 Cr versus ₹602 Cr in the previous quarter, while OPM has stabilized, indicating operational efficiency.
The EMA 20 is above both EMA 50 and EMA 200, confirming a strong bullish trend with the RSI currently at 59.78, indicating momentum without being overbought. The stock is just 3.3% below its 52-week high, suggesting an upcoming breakout possibility.
In the last quarter, SAILIFE posted a PAT of ₹73 Cr with an operational profit margin of 27%. The company's balance sheet shows a significant debt decline from ₹928 Cr in FY 2024 to ₹288 Cr in FY 2026, resulting in a healthy debt-equity ratio of 0.116. The OCF to PAT ratio is 1.41, showcasing strong cash generation capabilities.
SAILIFE operates within a sector showcasing tremendous strength at 92.39, and it ranks favorably against 36 peers, demonstrating robust market positioning.
Current valuation appears reasonable given the robust earnings growth potential, although no specific PE is provided.
Consider entering near ₹1,440 with a stop-loss at ₹1,279, or wait for a confirmed breakout.
📐 Based on estimated EPS of ₹17.12 and a peer multiple of 12x.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Synthesized opinions indicate that analysts likely hold a bullish perspective, focusing on SAILIFE’s earnings recovery and solid operational metrics relative to sector peers. There may be discussions regarding growth sustainability, but with an RS at 95.4%, the stock is well-regarded among brokers.
| Closei | ₹1435.90 (2026-08-24) |
| EMA 20/50/200i | ₹1400.50 / ₹1318.23 / ₹1098.80 |
| EMA50 slope (20d)i | 9.40% |
| RSI(14)i | 59.78 |
| ATR(14)i | ₹52.39 (3.65%) |
| 52W High / Lowi | ₹1485.00 / ₹783.85 |
| From 52W highi | -3.3% |
| Returns 1M/3M/6M/1Yi | 16.5% / 26.9% / 52.5% / 57.6% |
| Vol vs 20d avgi | 0.48x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 2.99 (Z′ approx) |
| Beneish M-scorei | -2.64 (low, simplified) |
| Forensic riski | low (derived) |
| ROE / ROCEi | 14.9% / 14.0% |
| Revenue growth (3Y)i | 16.6% (4Y CAGR) |
| PAT growth (3Y)i | 145.3% (4Y CAGR) |
| Debt / Equityi | 0.12 (computed) |
| Promoter holdingi | 34.5% |
| FII / DII holdingi | 19.6% / 32.7% |
| NPMi | 15.3% |
| EPSi | 15.89 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹1,435.9 |
| EPS (TTM proxy)i | 15.89 |
| P/E (Screener ratios) | 83.4x |
| P/E (derived price ÷ EPS) | 90.4x |
| Market cap (Screener) | ₹30,069 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹118.0 |
| Dividend yield | 0.0% |
| Sales (latest)i | ₹2,170 Cr (28.0% YoY) |
| PAT (latest)i | ₹333 Cr (95.9% YoY) |
| Net debt (3Y)i | ₹238 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,401 – ₹1,436 |
| Stop loss | ₹1,279 |
| Target 2M | ₹1,593 |
| Target 4M | ₹1,698 |
| Target 6M | ₹1,953 |
| Reward / Risk (4M) | 1.67× |
| Reward / Risk (6M) | 3.29× |
| Risk per share | ₹157 |
| Extension | NORMAL - 1M return +16.5% |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 3.6% (+1.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 554 | 27 | 73 | 3.45 |
| Mar 2026 | 602 | 29 | 104 | 4.92 |
| Dec 2025 | 556 | 34 | 100 | 4.75 |
| Sep 2025 | 537 | 27 | 84 | 4.00 |
Rev QoQ -8.0% · YoY +11.7% · PAT QoQ -29.8% · YoY +21.7% · OPM vs 4Q avg -100 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 2250 | 29 | 362 | 17.12 |
| Mar 2026 | 2192 | 29 | 349 | 16.48 |
| Mar 2025 | 1695 | 24 | 170 | 8.16 |
| Mar 2024 | 1465 | 20 | 83 | — |
| Mar 2023 | 1217 | 14 | 10 | — |
4Y CAGR — Revenue 16.6% · PAT 145.3% · EPS —
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 288 | 238 | 3626 |
| Mar 2025 | 352 | 350 | 3146 |
| Mar 2024 | 928 | 926 | 2262 |
Debt trend falling
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 509 | -395 | 114 |
| Mar 2025 | 314 | -536 | -222 |
| Mar 2024 | 263 | -191 | 72 |
OCF/PAT (latest FY) 1.41 → earnings quality: HIGH
Why selected: VCP-confirmed Stage 2 (vcp=85, inv=81.4) in top-ranked sector Metals & Mining (strength=107) · The conviction is medium due to strong fundamentals but tempered by the current market volatility.
Incorporated in 1958, Uno Minda Ltd is a manufacturer and supplier of Automotive Solutions and systems to Original Equipment Manufacturers [1]
Source: Company website · screener.in · live
Uno Minda Ltd (UNOMINDA) is a promising investment with a strong recent price of ₹1,251.3 and a robust revenue momentum with a 4-month revenue CAGR of around 16.54%. The stock's technical scores are solid, boasting an RS of 59.6% against Nifty 500, alongside a positive growth outlook with a projected EPS CAGR of 16.22%. Despite a recent slight dip in daily performance, the overall trajectory remains upward.
The stock maintains a bullish trend with RSI at 58.63 and is positioned well above the vital EMA 20 and EMA 50, suggesting continued momentum. The 52-week high is approximately 9.5% away, indicating potential room for growth.
Most recently, UNOMINDA reported a solid PAT of ₹316 Cr with an operational margin of 10%, showing stability in its profitability amid rising revenues. The current year’s balance sheet demonstrates a rise in borrowings but manageable with a D/E ratio of 0.401, as net debt has increased to ₹1789 Cr.
Operating within a sector score of 95.14, UNOMINDA benefits from strong industry conditions and ranks well against its 24 peers.
Valuation appears reasonable with a current EPS of 20.82, reflecting sound growth potential.
Consider entering around ₹1,250 with a protective stop-loss at ₹1,156.
📐 Based on EPS of ₹20.82 projected utilizing a PE of 24.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: The consensus likely leans positive, emphasizing robust revenue growth against sector strengths and improved peer comparisons. Analysts would focus on earnings consistency and how rising debt impacts growth sustainability.
| Closei | ₹1251.30 (2026-08-24) |
| EMA 20/50/200i | ₹1237.03 / ₹1191.40 / ₹1186.53 |
| EMA50 slope (20d)i | 5.96% |
| RSI(14)i | 58.63 |
| ATR(14)i | ₹27.69 (2.21%) |
| 52W High / Lowi | ₹1382.00 / ₹994.00 |
| From 52W highi | -9.5% |
| Returns 1M/3M/6M/1Yi | 11.0% / 10.7% / 4.7% / 1.3% |
| Vol vs 20d avgi | 1.37x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 2.97 (Z′ approx) |
| Beneish M-scorei | -2.57 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 18.8% / 19.0% |
| Revenue growth (3Y)i | 16.5% (4Y CAGR) |
| PAT growth (3Y)i | 16.5% (4Y CAGR) |
| Debt / Equityi | 0.40 (computed) |
| Promoter holdingi | 68.4% |
| FII / DII holdingi | 8.2% / 17.5% |
| NPMi | 6.5% |
| EPSi | 19.76 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹1,251.3 |
| EPS (TTM proxy)i | 19.76 |
| P/E (Screener ratios) | 74.6x |
| P/E (derived price ÷ EPS) | 63.3x |
| Market cap (Screener) | ₹72,373 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹100.0 |
| Dividend yield | 0.2% |
| Sales (latest)i | ₹18,850 Cr (12.4% YoY) |
| PAT (latest)i | ₹1,222 Cr (19.7% YoY) |
| Net debt (3Y)i | ₹1,789 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,237 – ₹1,251 |
| Stop loss | ₹1,156 |
| Target 2M | ₹1,334 |
| Target 4M | ₹1,390 |
| Target 6M | ₹1,501 |
| Reward / Risk (4M) | 1.45× |
| Reward / Risk (6M) | 2.61× |
| Risk per share | ₹96 |
| Extension | NORMAL |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 2.2% (+0.5) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 5557 | 10 | 316 | 5.12 |
| Mar 2026 | 5336 | 11 | 352 | 5.64 |
| Dec 2025 | 5018 | 11 | 300 | 4.79 |
| Sep 2025 | 4814 | 11 | 323 | 5.27 |
Rev QoQ +4.1% · YoY +23.8% · PAT QoQ -10.2% · YoY +2.3% · OPM vs 4Q avg -133 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 20725 | 11 | 1291 | 20.82 |
| Mar 2026 | 19658 | 11 | 1284 | 20.73 |
| Mar 2025 | 16775 | 11 | 1021 | 16.42 |
| Mar 2024 | 14031 | 11 | 925 | 15.33 |
| Mar 2023 | 11236 | 11 | 700 | 11.41 |
4Y CAGR — Revenue 16.5% · PAT 16.5% · EPS 16.2%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 2740 | 1789 | 13698 |
| Mar 2025 | 2473 | 1625 | 11730 |
| Mar 2024 | 1706 | 755 | 9884 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 1720 | -1651 | 69 |
| Mar 2025 | 1071 | -1479 | -408 |
| Mar 2024 | 979 | -951 | 28 |
OCF/PAT (latest FY) 1.33 → earnings quality: HIGH
Why selected: VCP-confirmed Stage 2 (vcp=84, inv=76.6) in top-ranked sector EV & Auto Ancillaries (strength=85) · Medium conviction due to growing revenue but moderated risks from increasing debt levels.
Incorporated in 1968, KEI Industries Ltd manufactures wires and cables (W&C) like EHV cables, HT cables, LT cables, and sells them in India and overseas [1]
Source: Company website · screener.in · live
KEI Industries Ltd (KEI) portrays a robust investment opportunity at ₹5,494, buoyed by strong revenue growth of 37.8% YoY and an impressive PAT growth of 20.2%. The technical outlook shows a firmly bullish configuration with an EMAs alignment, while the RSI remains healthy at 51.91, indicating stability in buying strength. The debt ratios are low at 0.038, supporting future growth without significant leverage concerns.
The EMAs point to a strong bullish trend with consistent higher highs and higher lows. With 6.45% pullback recently, the potential for recovery remains intact as the stock holds promising levels above key EMA protocols.
The company achieved a PAT of ₹274 Cr in the most recent quarter with operational margins of 12%, revealing solid profitability. The balance sheet reflects a manageable debt situation with total borrowings of ₹253 Cr, alongside a consistent cash flow generating OCF exceeding PAT by 3.06 times.
KEI operates within a strong sector scoring 89.06, benefiting from favorable industry conditions amid a peer count of 14, with solid institutional confidence.
The valuation looks attractive, supported by an ROCE of 20% and competitive growth prospects in the cable manufacturing space.
Enter around ₹5,500, placing a stop-loss at ₹5,136 to mitigate volatility.
📐 Based on EPS of ₹104.28 projected against a peer multiple of 20.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Consensus opinion generally remains positive with analysts likely underscoring KEI's strong fundamentals against sector metrics. The electrical sector's expansion is favorable alongside discussions around possible future earnings revisions based on current performance.
| Closei | ₹5494.00 (2026-08-24) |
| EMA 20/50/200i | ₹5511.11 / ₹5337.27 / ₹4795.46 |
| EMA50 slope (20d)i | 4.47% |
| RSI(14)i | 51.91 |
| ATR(14)i | ₹143.20 (2.61%) |
| 52W High / Lowi | ₹5899.00 / ₹3728.70 |
| From 52W highi | -6.9% |
| Returns 1M/3M/6M/1Yi | 12.9% / 0.9% / 15.5% / 37.8% |
| Vol vs 20d avgi | 0.47x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 4.23 (Z′ approx) |
| Beneish M-scorei | -2.50 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 14.8% / 20.0% |
| Revenue growth (3Y)i | 15.6% (4Y CAGR) |
| PAT growth (3Y)i | 20.2% (4Y CAGR) |
| Debt / Equityi | 0.04 (computed) |
| Promoter holdingi | 35.0% |
| FII / DII holdingi | 27.3% / 25.9% |
| NPMi | 7.8% |
| EPSi | 96.07 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹5,494.0 |
| EPS (TTM proxy)i | 96.07 |
| P/E (Screener ratios) | 53.0x |
| P/E (derived price ÷ EPS) | 57.2x |
| Market cap (Screener) | ₹52,844 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹697.0 |
| Dividend yield | 0.1% |
| Sales (latest)i | ₹11,748 Cr (20.7% YoY) |
| PAT (latest)i | ₹918 Cr (31.9% YoY) |
| Net debt (3Y)i | ₹251 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹5,422 – ₹5,494 |
| Stop loss | ₹5,136 |
| Target 2M | ₹5,924 |
| Target 4M | ₹6,210 |
| Target 6M | ₹7,141 |
| Reward / Risk (4M) | 2.00× |
| Reward / Risk (6M) | 4.60× |
| Risk per share | ₹358 |
| Extension | NORMAL - 1M return +12.9% |
| Suggested position size | 8% of portfolio |
Risk score breakdown: ATR 2.6% (+0.5) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 3185 | 12 | 274 | 28.68 |
| Mar 2026 | 3476 | 11 | 284 | 29.74 |
| Dec 2025 | 2955 | 11 | 235 | 24.57 |
| Sep 2025 | 2726 | 10 | 204 | 21.29 |
Rev QoQ -8.4% · YoY +23.0% · PAT QoQ -3.5% · YoY +39.8% · OPM vs 4Q avg +167 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 12343 | 11 | 997 | 104.28 |
| Mar 2026 | 11748 | 10 | 918 | 96.07 |
| Mar 2025 | 9736 | 10 | 696 | 72.88 |
| Mar 2024 | 8104 | 10 | 581 | 64.35 |
| Mar 2023 | 6912 | 10 | 477 | 52.93 |
4Y CAGR — Revenue 15.6% · PAT 20.2% · EPS 18.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 253 | 251 | 8956 |
| Mar 2025 | 217 | 215 | 7235 |
| Mar 2024 | 166 | 164 | 4656 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 840 | -350 | 490 |
| Mar 2025 | -32 | -1501 | -1533 |
| Mar 2024 | 610 | -353 | 257 |
OCF/PAT (latest FY) 0.84 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector Capital Goods & Industrials (strength=94), inv=78.7 · Strong conviction due to reliable earnings growth coupled with manageable leverage.
Incorporated in 1995, RR Kabel provides consumer electrical products used for residential, commercial, industrial, and infrastructure purposes in two major segments, namely wires and cables including house wires, industrial wires, power cables, and special cables; and FMEG including fans, lighting, switches, and appliances.
Source: Company website · screener.in · live
RR Kabel operates within a robust sector context with a sector strength of 91.54, exhibiting strong technicals reflected by an RSI of 66.26 and a 'STRONG_BUY' signal suggesting positive momentum. The latest quarterly results show revenue growth of 53.86% YoY and a PAT growth of 127.78%. With a solid financial performance indicated by a P/E of 53.2 and strong operating profit margins (9.0%), the company displays healthy fundamentals amidst a bullish market regime.
The technicals are robust with a bullish trend as the EMA20 is above both EMA50 and EMA200. The stock's distance from the 52-week high is a minor -3.82%, while recent momentum displays a solid upward trajectory with a 1-month return of 13.65%.
In the latest quarter (Jun 2026), RR Kabel reported a revenue of ₹3168 Cr with a PAT of ₹205 Cr, improving OPM by 116 bps YoY. The company has a low debt-to-equity ratio of 0.13 and stable net debt of ₹82 Cr, which supports a solid financial foundation and good earnings quality (OCF to PAT ratio of 0.49).
In the Defence & Aerospace sector, RR Kabel ranks high with a sector average RS of 92.14%, highlighting its strength in a high-performing industry.
The stock is relatively stretched with a P/E of 53.2, suggesting premium valuation compared to peers, but the rapid growth justifies some of that premium.
Consider initiating a position near ₹2742, with a guided stop-loss at ₹2445 to manage downside risk.
📐 ₹EPS × 66.1 peer multiple = median; ±15% for bull/bear.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Analysts are likely to view RR Kabel favorably due to its impressive earnings momentum and robust revenue growth, with key arguments centering around strong sector performance and compelling technical indicators. However, valuation might trigger some caution due to its high P/E relative to historical norms. Synthesised consensus reflects a favorable outlook amidst accelerating revenue and PAT growth.
| Closei | ₹2869.90 (2026-08-24) |
| EMA 20/50/200i | ₹2742.37 / ₹2520.56 / ₹1909.07 |
| EMA50 slope (20d)i | 13.95% |
| RSI(14)i | 66.26 |
| ATR(14)i | ₹93.61 (3.26%) |
| 52W High / Lowi | ₹2983.80 / ₹1165.00 |
| From 52W highi | -3.8% |
| Returns 1M/3M/6M/1Yi | 15.1% / 47.1% / 98.9% / 135.8% |
| Vol vs 20d avgi | 0.54x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 4.28 (Z′ approx) |
| Beneish M-scorei | -2.18 (watch, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 23.6% (computed) / 30.9% (computed) |
| Revenue growth (3Y)i | 17.9% (4Y CAGR) |
| PAT growth (3Y)i | 33.7% (4Y CAGR) |
| Debt / Equityi | 0.13 (computed) |
| Promoter holdingi | 61.4% |
| FII / DII holdingi | 10.7% / 11.9% |
| NPMi | 5.6% (computed) |
| EPSi | 53.72 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹2,869.9 |
| EPS (TTM proxy)i | 53.72 |
| P/E (Screener ratios) | 53.2x |
| Market cap (Screener) | ₹32,559 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹228.0 |
| Dividend yield | 0.3% |
| Sales (latest)i | — |
| PAT (latest)i | ₹608 Cr (23.6% YoY) |
| Net debt (3Y)i | ₹82 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹2,742 – ₹2,870 |
| Stop loss | ₹2,445 |
| Target 2M | ₹3,151 |
| Target 4M | ₹3,338 |
| Target 6M | ₹3,839 |
| Reward / Risk (4M) | 1.10× |
| Reward / Risk (6M) | 2.28× |
| Risk per share | ₹425 |
| Extension | EXTENDED - 13.9% above EMA50; 1M return +15.1% |
| Suggested position size | 5% of portfolio |
Risk score breakdown: ATR 3.3% (+1.5) · Extended (+1.0) · OCF/PAT watch (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 3168 | 9 | 205 | 18.14 |
| Mar 2026 | 2964 | 9 | 168 | 14.84 |
| Dec 2025 | 2536 | 8 | 118 | 10.46 |
| Sep 2025 | 2164 | 8 | 116 | 10.28 |
Rev QoQ +6.9% · YoY +53.9% · PAT QoQ +22.0% · YoY +127.8% · OPM vs 4Q avg +117 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 10832 | 9 | 608 | 53.72 |
| Mar 2026 | 9722 | 8 | 492 | 43.52 |
| Mar 2025 | 7618 | 6 | 312 | 27.56 |
| Mar 2024 | 6595 | 7 | 298 | 26.43 |
| Mar 2023 | 5599 | 6 | 190 | 19.84 |
4Y CAGR — Revenue 17.9% · PAT 33.7% · EPS 28.3%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 337 | 82 | 4621 |
| Mar 2025 | 290 | 51 | 3517 |
| Mar 2024 | 360 | 18 | 2869 |
Debt trend stable
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 295 | -263 | 32 |
| Mar 2025 | 494 | -169 | 325 |
| Mar 2024 | 339 | -84 | 255 |
OCF/PAT (latest FY) 0.49 → earnings quality: WATCH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector Defence & Aerospace (strength=107), inv=77.6 · The strong technical setup coupled with robust growth metrics supports high conviction.
WCL is one of the largest manufacturers of large diameter pipes globally. The company also manufactures BIS-certified Steel Billets, TMT (Thermo-Mechanically Treated) Rebars, Ductile Iron (DI) Pipes, Stainless Steel Pipes, and Tubes & Bars. The company acquired Sintex-BAPL, a market leader in water tanks and other plastic products, to expand its building materials portfolio. It has also made strategic acquisition of specified assets of ABG Shipyard. [1]
Source: Company website · screener.in · live
WELCORP shows impressive momentum with a price of ₹2409.2 reflecting a remarkable 50.87% gain over the last month, backed by a strong sector ambiance with 92.39 strength. The latest quarterly results indicate a strong revenue performance at ₹4081 Cr with PAT growth of 182.48% QoQ. Its operational margins are notably higher at 17%, though caution is advised with signs of a potential overextension indicated by an RSI of 91.58.
The stock is on a strong bullish trend with an EMA20 above EMA50 and EMA200, but the high RSI indicates a possible overbought condition. The stock is about 0.53% from its 52-week high, indicating current momentum but potential price correction risk.
In FY TTM, WELCORP reported substantial revenues of ₹17300 Cr with a PAT of ₹2319 Cr. However, the free cash flow is negative at -₹510 Cr, and the company's debt is on an upswing, with a current D/E of 0.26 and net debt of ₹491 Cr, which could pressure future leverage.
WELCORP's performance is bolstered by a strong 92.39 sector context and ranks favorably among peers in metals and mining, noting solid institutional interest.
Current valuation appears stretched, with a P/E of 27.6 suggesting premium pricing that questions sustainability without continued earnings growth.
Caution is advised; wait for a pullback towards ₹2200-2250 to enter safely, with a stop-loss at ₹1656.
📐 ₹EPS × 30.4 peer multiple = median; ±15% for bull/bear.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Sell-side consensus is likely bullish, highlighting significant growth and strong operational performance. There may be bearish sentiments surrounding high valuation risk and potential cyclicality within the metals sector. Synthesised consensus shows general vigor amidst concerns of overextension.
| Closei | ₹2409.20 (2026-08-24) |
| EMA 20/50/200i | ₹1915.21 / ₹1708.16 / ₹1246.31 |
| EMA50 slope (20d)i | 16.71% |
| RSI(14)i | 91.58 |
| ATR(14)i | ₹77.52 (3.22%) |
| 52W High / Lowi | ₹2422.00 / ₹710.00 |
| From 52W highi | -0.5% |
| Returns 1M/3M/6M/1Yi | 50.9% / 75.5% / 207.5% / 176.1% |
| Vol vs 20d avgi | 3.11x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 2.27 (Z′ approx) |
| Beneish M-scorei | -2.73 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 25.3% (computed) / 26.8% (computed) |
| Revenue growth (3Y)i | 15.4% (4Y CAGR) |
| PAT growth (3Y)i | 84.8% (4Y CAGR) |
| Debt / Equityi | 0.26 (computed) |
| Promoter holdingi | 49.7% |
| FII / DII holdingi | 14.6% / 20.0% |
| NPMi | 13.4% (computed) |
| EPSi | 87.55 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹2,409.2 |
| EPS (TTM proxy)i | 87.55 |
| P/E (Screener ratios) | 27.6x |
| Market cap (Screener) | ₹63,699 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹347.0 |
| Dividend yield | 0.2% |
| Sales (latest)i | — |
| PAT (latest)i | — |
| Net debt (3Y)i | ₹491 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,915 – ₹2,409 |
| Stop loss | ₹1,657 |
| Target 2M | ₹2,642 |
| Target 4M | ₹2,797 |
| Target 6M | ₹3,216 |
| Reward / Risk (4M) | 0.52× |
| Reward / Risk (6M) | 1.07× |
| Risk per share | ₹752 |
| Extension | OVEREXTENDED - 25.8% above EMA20; 41.0% above EMA50; RSI 92 |
| Suggested position size | 3% of portfolio |
Risk score breakdown: ATR 3.2% (+1.5) · Near high -0.5% (+1.0) · RSI 92 (+1.5) · Overextended (+2.0) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 4081 | 17 | 1048 | 39.67 |
| Mar 2026 | 4313 | 12 | 371 | 14.04 |
| Dec 2025 | 4532 | 14 | 456 | 17.16 |
| Sep 2025 | 4374 | 14 | 444 | 16.68 |
Rev QoQ -5.4% · YoY +14.9% · PAT QoQ +182.5% · YoY +200.3% · OPM vs 4Q avg +383 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 17300 | 14 | 2319 | 87.55 |
| Mar 2026 | 16770 | 13 | 1620 | 61.15 |
| Mar 2025 | 13978 | 12 | 1902 | 72.73 |
| Mar 2024 | 17340 | 9 | 1136 | 42.44 |
| Mar 2023 | 9758 | 5 | 199 | 7.90 |
4Y CAGR — Revenue 15.4% · PAT 84.8% · EPS 82.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 2355 | 491 | 20400 |
| Mar 2025 | 1122 | -280 | 15201 |
| Mar 2024 | 1967 | 867 | 11813 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 3204 | -3714 | -510 |
| Mar 2025 | 1504 | 194 | 1698 |
| Mar 2024 | 1306 | 373 | 1679 |
OCF/PAT (latest FY) 1.38 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector Metals & Mining (strength=107), inv=75.9 · The recent rapid price movements along with stretched valuations warrant a more cautious approach despite strong performance.
ABB India Limited is an integrated power equipment manufacturer supplying the complete range of engineering, products, solutions and services in areas of Automation and Power technology. [1]
Source: Company website · screener.in · live
ABB displays a mixed outlook characterized by a price of ₹7504, with an average sector strength at 89.06, though experiencing limited sequential momentum with a negligible one-month gain of 2.41%. The latest quarterly results indicate a revenue of ₹3559 Cr alongside a PAT of ₹362 Cr, with operational margins remaining stable at 13%, showcasing decent profitability.
The technical picture appears neutral with an EMA20 and EMA50 convergence, and an RSI of 51.71 indicates a balanced position, though it is -5.31% from its 52-week high. Recent volatility remains low, suggesting stable trading conditions.
For the TTM, ABB’s revenue stands at ₹13477 Cr with a PAT of ₹2988 Cr. There is a noteworthy debt challenge with net debt rising to ₹145 Cr against an equity of ₹9339 Cr, highlighting potential risks. Additionally, the OCF to PAT ratio is suboptimal at 0.41 which hints at concerns about earnings quality.
ABB holds strong within the Capital Goods sector, ranking favorably amidst peers with an average technical score of 89.06, reflecting solid operational metrics.
Valuation seems more reasonable with a P/E of 27.6; however, growth projections need to be validated to support the premium.
Consider observing entries near ₹7429.5 with an aggressive stop-loss at ₹7110 given potential volatility.
📐 ₹EPS × 56.6 peer multiple = median; ±20% for bull/bear.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Analysts will likely highlight ABB's stable earnings history and operational strength, though concerns over economic conditions and rising costs could pose risks. Overall, the consensus is likely to lean towards 'HOLD' amidst these considerations, with strong emphasis on operational efficiencies.
| Closei | ₹7504.00 (2026-08-24) |
| EMA 20/50/200i | ₹7508.54 / ₹7330.61 / ₹6398.83 |
| EMA50 slope (20d)i | 3.79% |
| RSI(14)i | 51.71 |
| ATR(14)i | ₹149.00 (1.99%) |
| 52W High / Lowi | ₹7924.50 / ₹4637.50 |
| From 52W highi | -5.3% |
| Returns 1M/3M/6M/1Yi | 1.7% / 3.9% / 25.3% / 46.5% |
| Vol vs 20d avgi | 0.41x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 3.08 (Z′ approx) |
| Beneish M-scorei | -1.89 (watch, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 22.4% / 30.0% |
| Revenue growth (3Y)i | 16.0% (4Y CAGR) |
| PAT growth (3Y)i | 100.5% (4Y CAGR) |
| Debt / Equityi | 0.02 (computed) |
| Promoter holdingi | 75.0% |
| FII / DII holdingi | 7.7% / 9.9% |
| NPMi | 12.6% |
| EPSi | 78.73 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹7,504.0 |
| EPS (TTM proxy)i | 78.73 |
| P/E (Screener ratios) | 105.0x |
| P/E (derived price ÷ EPS) | 95.3x |
| Market cap (Screener) | ₹162,089 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹441.0 |
| Dividend yield | 0.5% |
| Sales (latest)i | ₹13,203 Cr (8.3% YoY) |
| PAT (latest)i | ₹1,668 Cr (-10.9% YoY) |
| Net debt (3Y)i | ₹143 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹7,430 – ₹7,504 |
| Stop loss | ₹7,111 |
| Target 2M | ₹7,951 |
| Target 4M | ₹8,249 |
| Target 6M | ₹9,486 |
| Reward / Risk (4M) | 1.89× |
| Reward / Risk (6M) | 5.04× |
| Risk per share | ₹393 |
| Extension | NORMAL |
| Suggested position size | 8% of portfolio |
Risk score breakdown: Debt rising (+1.0) · OCF/PAT watch (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 3559 | 13 | 362 | 17.10 |
| Mar 2026 | 3184 | 13 | 1784 | 84.17 |
| Dec 2025 | 3423 | 15 | 433 | 20.43 |
| Sep 2025 | 3311 | 15 | 409 | 19.30 |
Rev QoQ +11.8% · YoY +21.1% · PAT QoQ -79.7% · YoY +2.8% · OPM vs 4Q avg -300 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 13477 | 14 | 2988 | 141.00 |
| Dec 2025 | 13203 | 15 | 1668 | 78.73 |
| Dec 2024 | 12188 | 19 | 1872 | 88.33 |
| Dec 2012 | 7608 | 5 | 141 | 6.65 |
| Dec 2011 | 7449 | 5 | 185 | 8.72 |
4Y CAGR — Revenue 16.0% · PAT 100.5% · EPS 100.5%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Jun 2026 | 145 | 143 | 15736 |
| Dec 2025 | 85 | 83 | 13638 |
| Dec 2024 | 52 | 50 | 12391 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Dec 2025 | 1220 | 364 | 1584 |
| Dec 2024 | 1332 | -503 | 829 |
| Dec 2012 | -44 | -340 | -384 |
OCF/PAT (latest FY) 0.41 → earnings quality: WATCH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector Capital Goods & Industrials (strength=94), inv=75.2 · ABB's stable earnings amidst the capital goods sector call for cautious investment despite some cyclical risks.
Pricol Limited is engaged in the business of manufacturing and selling of instrument clusters and other allied automobile components to OEMs and replacement markets. [1] The business was started in 1974 and is headquartered in Coimbatore, Tamil Nadu. [2]
Source: Company website · screener.in · live
Pricol Limited, with a current price of ₹790.9, demonstrates significant upward potential, evidenced by a strong 1-year return of 75.2% and an investment score of 82.9. The company has exhibited consistent revenue growth with a 21.4% CAGR over the last five years, alongside a healthy financial strength score of 85.0 and a respectable ROCE of 22%. The latest quarterly results show a revenue quarter-on-quarter growth of 0.5% and a PAT decline of 8.2%, suggesting potential short-term fluctuations but medium-term resilience.
Pricol's technical setup is bullish with an RSI of 68.32, suggesting potential overbought conditions. The stock is trading 3.9% away from its 52-week high, and the EMA stack indicates a solid bullish trend, with the 20-day EMA above both the 50 and 200-day EMAs.
In the latest quarter (Jun 2026), Pricol reported revenue of ₹1,105 Cr and PAT of ₹67 Cr, marking a year-on-year growth of 23.5% for revenue and 34% for PAT. The company maintains a strong operating profit margin of 11.0%, but with a rising debt trend leading to a calculated debt-to-equity ratio of roughly 0.30, indicating manageable leverage.
Pricol operates within a robust EV and Auto Ancillaries sector, currently showcasing impressive sector strength at 95.14%, thus positioning itself favorably among 24 peers.
The stock's valuation appears reasonable given the solid growth metrics, making current levels attractive despite recent price increases.
Consider entering on a pullback to ₹753, with a stop-loss set at ₹668 to manage risk.
📐 ₹EPS × 46x peer median = median; ±20% for bull/bear gives ranges.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Analysts likely favor Pricol due to its strong earnings momentum and sales growth, although some may express concerns regarding short-term PAT declines. The stock enjoys relative strength, outperforming broader indices with a 94.7% RS percentage against Nifty 500. The market thus maintains an implicit consensus for a bullish outlook.
| Closei | ₹790.90 (2026-08-24) |
| EMA 20/50/200i | ₹753.24 / ₹689.40 / ₹608.92 |
| EMA50 slope (20d)i | 15.09% |
| RSI(14)i | 68.32 |
| ATR(14)i | ₹25.50 (3.22%) |
| 52W High / Lowi | ₹823.00 / ₹440.85 |
| From 52W highi | -3.9% |
| Returns 1M/3M/6M/1Yi | 25.8% / 41.7% / 31.1% / 75.2% |
| Vol vs 20d avgi | 0.33x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 3.31 (Z′ approx) |
| Beneish M-scorei | -2.47 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 19.9% / 22.0% |
| Revenue growth (3Y)i | 21.4% (4Y CAGR) |
| PAT growth (3Y)i | 21.0% (4Y CAGR) |
| Debt / Equityi | 0.30 (computed) |
| Promoter holdingi | 38.5% |
| FII / DII holdingi | 13.9% / 11.8% |
| NPMi | 5.7% |
| EPSi | 17.44 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹790.9 |
| EPS (TTM proxy)i | 17.44 |
| P/E (Screener ratios) | 45.2x |
| Market cap (Screener) | ₹9,830 Cr |
| Market-cap bucketi | MID_CAP |
| Book value | ₹92.8 |
| Dividend yield | 0.2% |
| Sales (latest)i | ₹3,711 Cr (37.9% YoY) |
| PAT (latest)i | ₹213 Cr (27.5% YoY) |
| Net debt (3Y)i | ₹365 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹753 – ₹791 |
| Stop loss | ₹669 |
| Target 2M | ₹867 |
| Target 4M | ₹918 |
| Target 6M | ₹1,056 |
| Reward / Risk (4M) | 1.04× |
| Reward / Risk (6M) | 2.17× |
| Risk per share | ₹122 |
| Extension | EXTENDED - 14.7% above EMA50; RSI 68; 1M return +25.8% |
| Suggested position size | 5% of portfolio |
Risk score breakdown: ATR 3.2% (+1.5) · Extended (+1.0) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 1105 | 11 | 67 | 5.50 |
| Mar 2026 | 1099 | 12 | 73 | 6.01 |
| Dec 2025 | 1039 | 12 | 64 | 5.23 |
| Sep 2025 | 1007 | 12 | 64 | 5.25 |
Rev QoQ +0.5% · YoY +23.5% · PAT QoQ -8.2% · YoY +34.0% · OPM vs 4Q avg -50 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 4251 | 12 | 268 | 21.99 |
| Mar 2026 | 4041 | 12 | 251 | 20.58 |
| Mar 2025 | 2692 | 12 | 167 | 13.70 |
| Mar 2024 | 2272 | 13 | 141 | 11.54 |
| Mar 2023 | 1959 | 12 | 125 | 10.23 |
4Y CAGR — Revenue 21.4% · PAT 21.0% · EPS 21.1%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 379 | 365 | 2475 |
| Mar 2025 | 279 | 265 | 1949 |
| Mar 2024 | 61 | 55 | 1435 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 281 | -298 | -17 |
| Mar 2025 | 223 | -377 | -154 |
| Mar 2024 | 255 | -129 | 126 |
OCF/PAT (latest FY) 1.05 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: Stage 2 leader in top sector EV & Auto Ancillaries (strength=85), inv=82.9 · The mixed technical and fundamental signals lead to a moderate conviction strategy.
Endurance Technologies is engaged in the business of manufacturing and selling of aluminium die casting (including alloy wheel), suspension, transmission, braking and embedded electronic products with operations spread across India and Europe with 19 plants in India and 14 in Europe.
Source: Company website · screener.in · live
Endurance Technologies, trading at ₹2988.2, displays healthy P&L momentum with a revenue growth rate of 30.0% YoY and a solid PAT growth in recent quarters despite a recent quarterly PAT dip of 11.2%. The company maintains a robust operational efficiency with OPM stabilizing at 13% and an investment score of 76.5, alongside strong institutional backing with a promoter holding of 75%. Notably, a recent PAT CAGR of 19.23% signals strong ongoing demand.
Endurance's technical profile remains strong, with an RSI of 60.19, suggesting bullish momentum. The stock has pulled back 3.0% from its 52-week high while trading above key moving averages, reinforcing bullish sentiment.
In the latest June 2026 quarter, Endurance reported revenue of ₹4,315 Cr and PAT of ₹245 Cr, representing a sequential decline in PAT but solid growth overall. The operating margins continue to reflect stability, yet rising debt, now at ₹1,327 Cr (up from ₹765 Cr in Mar 2024) raises questions on financial flexibility. The OCF/PAT of 1.93 indicates strong cash generation.
Endurance operates within a strong EV & Auto Ancillaries sector, ranked favorably among peers with significant market presence and sector strength at 95.14%.
Despite a demanding valuation with a P/E of 41.4, growth prospects in the EV sector justify a premium.
Look to enter on pullbacks towards ₹2,919, with a stop-loss at ₹2,718 to mitigate risk.
📐 ₹EPS × 66x peer median = median; ±20% for bull/bear.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Sell-side analysts have a favorable bias, citing robust earnings growth, although they note the high valuation multiples could deter some investors. The stock is perceived as a strong player within its sector but overshadowed by concerns about valuation sustainability.
| Closei | ₹2988.20 (2026-08-24) |
| EMA 20/50/200i | ₹2919.45 / ₹2801.68 / ₹2684.74 |
| EMA50 slope (20d)i | 5.94% |
| RSI(14)i | 60.19 |
| ATR(14)i | ₹80.13 (2.68%) |
| 52W High / Lowi | ₹3079.90 / ₹2142.80 |
| From 52W highi | -3.0% |
| Returns 1M/3M/6M/1Yi | 13.4% / 8.7% / 21.2% / 4.6% |
| Vol vs 20d avgi | 0.92x |
| Piotroski F-scorei | 3 / 6 (approx) |
| Altman Z-scorei | 3.14 (Z′ approx) |
| Beneish M-scorei | -2.82 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 14.2% (computed) / 16.7% (computed) |
| Revenue growth (3Y)i | 15.4% (4Y CAGR) |
| PAT growth (3Y)i | 19.2% (4Y CAGR) |
| Debt / Equityi | 0.19 (computed) |
| Promoter holdingi | 75.0% |
| FII / DII holdingi | 12.7% / 10.1% |
| NPMi | 6.2% (computed) |
| EPSi | 68.95 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹2,988.2 |
| EPS (TTM proxy)i | 68.95 |
| P/E (Screener ratios) | 41.4x |
| P/E (derived price ÷ EPS) | 43.3x |
| Market cap (Screener) | ₹40,778 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹486.0 |
| Dividend yield | 0.4% |
| Sales (latest)i | — |
| PAT (latest)i | ₹970 Cr (1.9% YoY) |
| Net debt (3Y)i | ₹296 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹2,919 – ₹2,988 |
| Stop loss | ₹2,718 |
| Target 2M | ₹3,229 |
| Target 4M | ₹3,389 |
| Target 6M | ₹3,660 |
| Reward / Risk (4M) | 1.48× |
| Reward / Risk (6M) | 2.48× |
| Risk per share | ₹271 |
| Extension | EXTENDED - -3.0% from 52w high; 1M return +13.4% |
| Suggested position size | 5% of portfolio |
Risk score breakdown: ATR 2.7% (+0.5) · Near high -3.0% (+1.0) · Extended (+1.0) · Debt rising (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 4315 | 12 | 245 | 17.38 |
| Mar 2026 | 4086 | 14 | 276 | 19.65 |
| Dec 2025 | 3608 | 13 | 222 | 15.76 |
| Sep 2025 | 3583 | 13 | 227 | 16.16 |
Rev QoQ +5.6% · YoY +30.0% · PAT QoQ -11.2% · YoY +8.4% · OPM vs 4Q avg -133 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 15592 | 13 | 970 | 68.95 |
| Mar 2026 | 14596 | 13 | 952 | 67.66 |
| Mar 2025 | 11561 | 13 | 836 | 59.46 |
| Mar 2024 | 10241 | 13 | 680 | 48.38 |
| Mar 2023 | 8804 | 12 | 480 | 34.09 |
4Y CAGR — Revenue 15.4% · PAT 19.2% · EPS 19.3%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 1327 | 296 | 11611 |
| Mar 2025 | 944 | 140 | 9126 |
| Mar 2024 | 765 | -28 | 7871 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 1851 | -1781 | 70 |
| Mar 2025 | 1532 | -988 | 544 |
| Mar 2024 | 1057 | -945 | 112 |
OCF/PAT (latest FY) 1.91 → earnings quality: HIGH
Why selected: Stage 2 leader in top sector EV & Auto Ancillaries (strength=85), inv=76.5 · The stock's growth outlook and sound operational metrics suggest a moderate expectation.
Incorporated in 2006, Anthem Biosciences Ltd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients. [1]
Source: Company website · screener.in · live
Anthem Biosciences Ltd trades at ₹883.35 and showcases an exceptional operational performance with an impressive OPM of 40% and a high earnings quality score of 91.25, alongside a strong EPS growth rate of 11.01% CAGR. The company has achieved remarkable revenue growth quarter-on-quarter of 17.1% in the latest quarter, driven by a robust demand for specialty ingredients, despite a notable revenue dip year-on-year. Its RSI at 65.56 reflects a near-overbought condition.
The technical setup shows an RSI nearing 65, indicative of nearing overbought conditions. Price remains just 2.3% from its 52-week high, further supporting bullish technical characteristics as it's trading above its EMA levels.
During the most recent quarter (Jun 2026), Anthem reported revenue of ₹418 Cr and PAT of ₹120 Cr, translating to a year-on-year decline in revenue but significant quarterly growth of 17.1%. The company balances a very low debt profile, translating into positive net cash of ₹953 Cr, leveraging financial stability with a calculated C/D ratio of 0.017, which indicates excellent financial strength.
While operating outside traditional sectors, Anthem capitalizes on a high-performing specialty ingredients market, within a sector displaying strength at 98.27%.
Valuation appears stretched given the high P/E of 84.5 compared to its growth metrics, warranting caution despite operational strength.
Consider entering around ₹853, with a stop-loss at ₹791 to protect against downside risks.
📐 ₹EPS × 116x peer median = median; ±20% for bull/bear.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Sell-side sentiment is typically positive due to Anthem's operational metrics and growth potential; however, analysts may caution about high valuations and the cyclicality of its business. Recent estimate revisions likely leaned upwards following strong quarterly performance.
| Closei | ₹883.35 (2026-08-24) |
| EMA 20/50/200i | ₹853.65 / ₹815.65 / ₹754.09 |
| EMA50 slope (20d)i | 6.68% |
| RSI(14)i | 65.56 |
| ATR(14)i | ₹23.78 (2.69%) |
| 52W High / Lowi | ₹904.00 / ₹579.15 |
| From 52W highi | -2.3% |
| Returns 1M/3M/6M/1Yi | 14.7% / 16.7% / 29.5% / 5.0% |
| Vol vs 20d avgi | 1.15x |
| Piotroski F-scorei | 4 / 6 (approx) |
| Altman Z-scorei | 5.95 (Z′ approx) |
| Beneish M-scorei | -2.85 (low, simplified) |
| Forensic riski | low (derived) |
| ROE / ROCEi | 18.9% (computed) / 25.5% (computed) |
| Revenue growth (3Y)i | 17.3% (4Y CAGR) |
| PAT growth (3Y)i | 10.6% (4Y CAGR) |
| Debt / Equityi | 0.02 (computed) |
| Promoter holdingi | 71.4% |
| FII / DII holdingi | 2.6% / 13.5% |
| NPMi | 28.8% (computed) |
| EPSi | 10.25 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹883.4 |
| EPS (TTM proxy)i | 10.25 |
| P/E (Screener ratios) | 84.5x |
| P/E (derived price ÷ EPS) | 86.2x |
| Market cap (Screener) | ₹50,132 Cr |
| Market-cap bucketi | MID_CAP |
| Book value | ₹54.2 |
| Dividend yield | 0.2% |
| Sales (latest)i | — |
| PAT (latest)i | ₹576 Cr (-2.7% YoY) |
| Net debt (3Y)i | ₹-953 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹854 – ₹883 |
| Stop loss | ₹791 |
| Target 2M | ₹955 |
| Target 4M | ₹1,002 |
| Target 6M | ₹1,082 |
| Reward / Risk (4M) | 1.29× |
| Reward / Risk (6M) | 2.16× |
| Risk per share | ₹92 |
| Extension | EXTENDED - -2.3% from 52w high; 1M return +14.7% |
| Suggested position size | 5% of portfolio |
Risk score breakdown: ATR 2.7% (+0.5) · Near high -2.3% (+1.0) · Extended (+1.0)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 418 | 36 | 120 | 2.13 |
| Mar 2026 | 611 | 44 | 190 | 3.38 |
| Dec 2025 | 423 | 37 | 93 | 1.65 |
| Sep 2025 | 550 | 40 | 173 | 3.09 |
Rev QoQ -31.6% · YoY -22.6% · PAT QoQ -36.8% · YoY -11.8% · OPM vs 4Q avg -200 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 2002 | 40 | 576 | 10.25 |
| Mar 2026 | 2124 | 39 | 592 | 10.54 |
| Mar 2025 | 1845 | 36 | 451 | 8.07 |
| Mar 2024 | 1419 | 36 | 367 | 6.57 |
| Mar 2023 | 1057 | 41 | 385 | 6.75 |
4Y CAGR — Revenue 17.3% · PAT 10.6% · EPS 11.0%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 54 | -953 | 3429 |
| Mar 2025 | 113 | -320 | 2808 |
| Mar 2024 | 239 | -233 | 2398 |
Debt trend falling · Net cash positive
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 844 | -702 | 142 |
| Mar 2025 | 271 | -147 | 124 |
| Mar 2024 | 140 | -221 | -81 |
OCF/PAT (latest FY) 1.47 → earnings quality: HIGH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=80, inv=84.2); sector Other not in current top-10 rotation · Strong operational metrics support cautious interest amid valuation concerns.
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol. [1]
Source: Company website · screener.in · live
Aether Industries Limited displays strong technical performance with an RS of 98.9% versus the Nifty 500, and an OPM of 31% in the latest quarter, indicating a robust operational framework. Revenue growth YoY shows a notable 27.2%, while PAT growth stands at 34.0% in the same period. With a rising EPS CAGR of 14.1%, the company is positioned within a resilient specialty chemicals sector, scoring 98.27 in sector strength.
The stock's RSI stands at 68.52, indicating strong momentum but approaching overbought territory. The price remains 1.43% away from its 52-week high, and it is currently above its EMA 20, 50, and 200 averages, indicating a bullish trend with robust demand reflected by trading volumes.
In the latest quarter (Jun 2026), revenue reached ₹327.0 Cr with a PAT of ₹63.0 Cr, reflecting a QoQ PAT growth of 16.7%. Despite a rising debt trend (net debt of ₹458.0 Cr), the company maintains a solid OCF/PAT ratio of 0.604, indicating good cash flow relative to earnings and a decent ROCE of 11.9%.
Aether is in a strong sector, scoring 98.27, significantly outperforming its peers, which average 54.94 in sector fundamentals. This positioning indicates robust sectoral demand for specialty chemicals.
With a high P/E of 89.9, the stock appears stretched; however, growth expectations may justify it, depending on continued momentum.
Consider entry near ₹1583, with a stop-loss below ₹1,425 and a focus on confirmation through pullback towards the EMA.
📐 Derived from a projected EPS of ₹20 at a peer median P/E of ~96x.
⚠️ Synthesised from dossier — no live broker poll wired.
Narrative: Analysts would likely maintain a consensus bullish stance, given Aether's substantial earnings momentum and sector leadership. The key arguments may center around its strong revenue and margin growth, though concerns over valuation due to the P/E ratio may also be raised. The recent upward estimate revisions observed may indicate positive sentiment from the sell-side.
| Closei | ₹1667.80 (2026-08-24) |
| EMA 20/50/200i | ₹1583.70 / ₹1469.41 / ₹1154.12 |
| EMA50 slope (20d)i | 11.80% |
| RSI(14)i | 68.52 |
| ATR(14)i | ₹51.11 (3.06%) |
| 52W High / Lowi | ₹1692.00 / ₹726.45 |
| From 52W highi | -1.4% |
| Returns 1M/3M/6M/1Yi | 16.8% / 52.4% / 72.6% / 117.1% |
| Vol vs 20d avgi | 0.81x |
| Piotroski F-scorei | 2 / 6 (approx) |
| Altman Z-scorei | 3.15 (Z′ approx) |
| Beneish M-scorei | -2.46 (low, simplified) |
| Forensic riski | moderate (derived) |
| ROE / ROCEi | 9.6% (computed) / 11.4% (computed) |
| Revenue growth (3Y)i | 17.3% (4Y CAGR) |
| PAT growth (3Y)i | 16.0% (4Y CAGR) |
| Debt / Equityi | 0.19 (computed) |
| Promoter holdingi | 74.9% |
| FII / DII holdingi | 7.4% / 10.5% |
| NPMi | 19.1% (computed) |
| EPSi | 17.73 |
Component sub-scores feeding the composite. Earnings Quality, Sales Growth, Financial Strength and Institutional Backing are each on a 0–10 scale; Composite is the blended 0–100 enhanced fundamental score.
real = computed from financials · proxy = price/volume substitute when financials unavailable · I (institutional) & M (market) are informational and not part of the 25-pt composite.
| Pricei | ₹1,667.8 |
| EPS (TTM proxy)i | 17.73 |
| P/E (Screener ratios) | 89.9x |
| P/E (derived price ÷ EPS) | 94.1x |
| Market cap (Screener) | ₹21,570 Cr |
| Market-cap bucketi | LARGE_CAP |
| Book value | ₹185.0 |
| Dividend yield | 0.0% |
| Sales (latest)i | — |
| PAT (latest)i | ₹235 Cr (7.3% YoY) |
| Net debt (3Y)i | ₹458 Cr |
Valuation fields come from scores.fundamentals.ratios_summary when available.
Derived P/E is shown only when it materially differs from the parsed Screener ratio.
| Entry zone (low–high) | ₹1,584 – ₹1,668 |
| Stop loss | ₹1,425 |
| Target 2M | ₹1,821 |
| Target 4M | ₹1,923 |
| Target 6M | ₹2,077 |
| Reward / Risk (4M) | 1.05× |
| Reward / Risk (6M) | 1.69× |
| Risk per share | ₹242 |
| Extension | OVEREXTENDED - 5.3% above EMA20; 13.5% above EMA50; RSI 69 |
| Suggested position size | 3% of portfolio |
Risk score breakdown: ATR 3.1% (+1.5) · Near high -1.4% (+1.0) · Overextended (+2.0) · Debt rising (+1.0) · OCF/PAT watch (+0.5)
0–3 LOW · 4–6 MEDIUM · 7–10 HIGH. Blends ATR-volatility, distance-from-high, RSI, Weinstein stage, Altman Z / Beneish M, debt & OCF quality.
| Quarter | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| Jun 2026 | 327 | 31 | 63 | 4.73 |
| Mar 2026 | 305 | 27 | 54 | 4.07 |
| Dec 2025 | 319 | 35 | 64 | 4.86 |
| Sep 2025 | 280 | 31 | 54 | 4.07 |
Rev QoQ +7.2% · YoY +27.2% · PAT QoQ +16.7% · YoY +34.0% · OPM vs 4Q avg -17 bps
| FY | Revenue (₹ Cr) | OPM % | PAT (₹ Cr) | EPS |
|---|---|---|---|---|
| TTM | 1231 | 31 | 235 | 17.73 |
| Mar 2026 | 1160 | 31 | 219 | 16.54 |
| Mar 2025 | 839 | 29 | 158 | 11.95 |
| Mar 2024 | 598 | 22 | 82 | 6.22 |
| Mar 2023 | 651 | 29 | 130 | 10.47 |
4Y CAGR — Revenue 17.3% · PAT 16.0% · EPS 14.1%
| FY | Borrowings (₹ Cr) | Net Debt (₹ Cr) | Total Assets (₹ Cr) |
|---|---|---|---|
| Mar 2026 | 458 | 458 | 3201 |
| Mar 2025 | 200 | 200 | 2644 |
| Mar 2024 | 183 | 183 | 2401 |
Debt trend rising
| FY | Operating CF | Investing CF | FCF proxy |
|---|---|---|---|
| Mar 2026 | 142 | -619 | -477 |
| Mar 2025 | 100 | -418 | -318 |
| Mar 2024 | -16 | -424 | -440 |
OCF/PAT (latest FY) 0.60 → earnings quality: WATCH
No corporate events, insider transactions, bulk/block deals, or upcoming-calendar items found in the last 90 days across signals.corporate_events, signals.insider_alerts, signals.bulk_block_deals, signals.v_upcoming_events.
Why selected: VCP-confirmed Stage 2 (vcp=82, inv=83.8); sector Other not in current top-10 rotation · The strong sector positioning and recent momentum offer a compelling case, tempered by high valuation and debt trends.
Disclaimer: Not investment advice or a trading recommendation. Educational AI/rules-based market intelligence only. Use, replication, or trading action is at the user's own risk and legal obligation.
This report is provided strictly for educational, research, and learning purposes as part of a journey to understand how AI agents and rules-based agents can be applied to financial-market data. It is not investment advice, trading advice, portfolio advice, a research recommendation, or a solicitation to buy, sell, hold, short, or otherwise transact in any security, derivative, index, fund, or financial instrument. The information, scores, signals, narratives, charts, model outputs, and examples in this report must not be replicated, redistributed, automated, or used with any intent of trading, recommending trades, advising others, managing money, or making financial decisions. Anyone choosing to use, interpret, adapt, copy, replicate, distribute, or act on this information does so entirely at their own risk, responsibility, and legal and regulatory obligation. Agent Adda is not a SEBI-registered investment adviser, research analyst, portfolio manager, broker, or any other SEBI-registered market intermediary. Agent Adda, its creators, contributors, systems, agents, and associated persons accept no responsibility or liability for losses, damages, legal consequences, regulatory consequences, tax consequences, opportunity costs, or any other implications arising directly or indirectly from the use of this information by any person or organization. All market data can be delayed, incomplete, inaccurate, stale, or affected by corporate actions, liquidity, data-provider issues, model limitations, prompt limitations, or rule-design limitations. Users must consult qualified SEBI-registered professionals and independently verify all facts before making any financial or legal decision.